4/A: ORAGENICS Director Amends Filing, Reports Stock Sale & Option Grant

ORAGENICS Director Fred Telling filed an amended Form 4, disclosing a sale of 210 common shares and the grant of 125,000 stock options, while correcting previous beneficial ownership due to a reverse stock split.

Summary

• Fred Telling, a Director and 10% Owner of ORAGENICS INC, filed an amended Form 4 to correct previously reported beneficial ownership.
• The amendment reflects a 1-for-30 reverse stock split of the company's outstanding common stock, which was not included in the prior Form 4.
• Telling sold 210 shares of common stock on December 12, 2025, at a weighted average price of $0.9446 per share.
• He was granted 125,000 non-employee director options to purchase common stock on December 11, 2025, with an exercise price of $0.93 per share.
• These options were awarded under the Company's 2021 Equity Incentive Plan, as amended, and vest immediately, expiring on December 11, 2035.
• Following these transactions and the correction, Telling beneficially owns 948 shares of common stock directly and 125,000 derivative securities (options).

Sentiment

Score: 5

Explanation: Neutral. The filing reports routine insider transactions (a small sale and an option grant) and an administrative correction related to a reverse stock split. The reverse split itself could be viewed negatively, but the filing is purely transactional and does not provide new operational or financial performance data.

Positives

• Grant of 125,000 stock options to Director Fred Telling, aligning his interests with shareholders.
• The granted options vest immediately, providing immediate equity incentive to the director.

Negatives

• Director Fred Telling sold 210 shares of common stock.
• The need for an amendment due to an unreflected reverse stock split suggests a potential administrative oversight in the initial filing process.

Risks

• The 1-for-30 reverse stock split indicates a significant reduction in the number of outstanding shares, which is often a measure taken by companies to increase share price and meet listing requirements, potentially signaling underlying financial challenges or a need to improve stock perception.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance beyond the expiration date of the granted options.

Management Comments

• The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.

Industry Context

Form 4 filings are standard for reporting insider transactions. The reverse stock split is a more significant corporate action, often indicating a company's efforts to maintain stock exchange listing compliance or improve stock perception, which can be a sign of past underperformance relative to industry peers.

Comparison to Industry Standards

• Reverse stock splits are not uncommon for micro-cap or small-cap companies struggling with low stock prices, often implemented to meet exchange listing requirements or improve stock market perception. While this action can address technical trading issues, it does not inherently improve the company's underlying business fundamentals.
• The grant of stock options to directors is a standard practice in corporate compensation, aligning management incentives with shareholder value. The size of the option grant (125,000 shares) is substantial relative to the reported direct common stock ownership (948 shares) post-split, indicating a significant equity incentive component for the director.

Corporate Governance

Stakeholder Impact

• Shareholders: The reverse stock split impacts the number of shares owned and per-share metrics. The director's sale of a small number of shares and grant of options are routine insider activities that provide transparency into insider holdings and incentives.
• Management/Directors: Fred Telling's compensation includes a significant option grant, aligning his financial interests with the company's stock performance.

Next Steps

• Fred Telling will provide full information regarding the number of shares sold at each separate price within the reported range upon request from the issuer, any security holder, or the SEC staff.

Key Dates

Recommendation

This filing primarily corrects an administrative error related to a reverse stock split and reports routine insider transactions (a small sale and a director option grant). It does not provide new fundamental information about the company's operations, financial performance, or strategic direction that would warrant a change in investment thesis. Therefore, a 'hold' recommendation is appropriate as there's no new information to justify buying or selling based solely on this amendment.

Keywords

ORAGENICS, OGEN, Form 4/A, SEC Filing, Insider Trading, Stock Options, Director Compensation, Reverse Stock Split, Beneficial Ownership, Equity Incentive Plan